pharmacie et médicaments – Non publication des textes d'application pour les médicaments en accès précoce

This written question concerns the non-publication of implementing texts for medicines available through early access schemes. It seeks clarification on the reasons behind this delay and its impact on patients and healthcare professionals. The question highlights potential issues for patients awaiting access to innovative treatments and for pharmaceutical companies navigating regulatory processes. It calls for transparency and timely information.